Effect of cigarette smoking on levels of bioavailable testosterone in healthy men

2001 ◽  
Vol 100 (6) ◽  
pp. 661 ◽  
Author(s):  
Katherine M. ENGLISH ◽  
Peter J. PUGH ◽  
Helen PARRY ◽  
Nanette E. SCUTT ◽  
Kevin S. CHANNER ◽  
...  
The Lancet ◽  
1917 ◽  
Vol 190 (4903) ◽  
pp. 232-236 ◽  
Author(s):  
John Parkinson ◽  
Hilmar Koefod

2001 ◽  
Vol 100 (6) ◽  
pp. 661-665 ◽  
Author(s):  
Katherine M. ENGLISH ◽  
Peter J. PUGH ◽  
Helen PARRY ◽  
Nanette E. SCUTT ◽  
Kevin S. CHANNER ◽  
...  

The effect of smoking on androgen levels is important given the recent interest in the link between low levels of androgens and the development of cardiovascular disease. Numerous studies examining the effects of cigarette smoking on the levels of total and free testosterone have reported conflicting findings, but there has been no accurate assessment of the effects of cigarette smoking on the levels of bioavailable testosterone [not bound to sex hormone-binding globulin (SHBG)]. We attempted to determine whether smoking affects the level of bioavailable testosterone. We undertook a case-control study of 25 healthy male smokers and 25 healthy never-smokers, matched by age and body mass index. Early morning levels of total, free and bioavailable testosterone, 17β-oestradiol, SHBG and cotinine were determined and compared between the two groups. Levels of total (18.5 ± 4.6 ± nM versus 15.1 ± 4.9 ± nM, P = 0.01) and free testosterone (462 ± 91 ± pM versus 402 ± 93 ± pM, P = 0.03) were found to be higher in smokers compared with non-smokers respectively, as was SHBG (34.1 ± 12.8 versus 28.1 ± 9.0 ± nM, P = 0.06). There were no significant differences in the levels of bioavailable testosterone (3.78 ± 1.59 versus 3.51 ± 1.26 ± nM, P = 0.49) or 17β-oestradiol (44.5 ± 11.4 versus 42.3 ± 11.5 ± pM, P = 0.50) between smokers and non-smokers respectively. These data suggest that cigarette smoking has no significant effect on the biologically active fraction of testosterone, but may influence the levels of total and free testosterone through changes in the levels of SHBG.


1980 ◽  
Vol 25 (1) ◽  
pp. 13-17 ◽  
Author(s):  
G. D. O. Lowe ◽  
M. M. Drummond ◽  
C.D. Forbes ◽  
J. C. Barbenel

We measured blood viscosity and its major determinants (haematocrit, plasma fibrinogen and plasma viscosity) in 90 apparently healthy men aged 16 to 80 years. Cigarette-smokers (n=45) had higher levels of blood viscosity, haematocrit and fibrinogen (p<0.001) and plasma viscosity (p<0.025) than non-smokers (n=45). Blood viscosity was still higher in smokers after correction to a standard haematocrit (p<0.02). Fibrinogen, corrected blood viscosity and plasma viscosity rose with age in both groups, but young smokers had prematurely elevated levels of these variables and less pronounced rises with age. These results show that age and cigarette-smoking must be considered in studies of blood and plasma viscosity, and provide further evidence for an association between viscosity and arterial disease.


Cytokine ◽  
2007 ◽  
Vol 39 (2) ◽  
pp. 116-122 ◽  
Author(s):  
Kyung-Kyun Shin ◽  
Yangsoo Jang ◽  
Soo Jeong Koh ◽  
Jey Sook Chae ◽  
Oh Yoen Kim ◽  
...  

2007 ◽  
Vol 9 (10) ◽  
pp. 1027-1032 ◽  
Author(s):  
Teruo Nagaya ◽  
Hideyo Yoshida ◽  
Hidekatsu Takahashi ◽  
Makoto Kawai

2006 ◽  
Vol 38 (Supplement) ◽  
pp. S420
Author(s):  
Andrea K. Creasy ◽  
Webb A. Smith ◽  
Robert A. McMahan ◽  
Richard J. Bloomer ◽  
Larry Weiss

2015 ◽  
Vol 36 (7) ◽  
pp. 847-850 ◽  
Author(s):  
Farahnaz Ghahremanfard ◽  
Vahid Semnani ◽  
Raheb Ghorbani ◽  
Farhad Malek ◽  
Ali Behzadfar ◽  
...  

1982 ◽  
Vol 47 (03) ◽  
pp. 259-264 ◽  
Author(s):  
F C Chao ◽  
J L Tullis ◽  
C A Alper ◽  
R J Glynn ◽  
J E Silbert

SummaryBlood samples were obtained on four different occasions from 18 cigarette smoking and 34 non-smoking healthy men (age 4Hl9) and analped to assess age- and smoking-associated changes in plasma proteins, btood coagulation and platelet functions. C-ollagen-induced platele t aggregation was signifi cantly inclreased with agng in non-smokers. Significant gfuanges in chronic smokers were increases in platelet count and fibrinogen in plasma; elevation of platelet factor-3 (PF-3) activity in plateletpoor plasma (PPP); increase in serum levels of a1-antitr,?sin, orosomucoid, haptoglobin and properdin factor B; and sfoeftsning of the lag period of collagen-induced platelet aggregation. Filtration of PPP through Mllipore fiIters removed PF-3 membranes. The differen@s in PF-3 activities in fiItered plasma were no longer significant between smokers and non-smokers. Results suggest that chronic smokers have higher levels of acute phase proteins reflecting underlyrng inflammatory processes, and higher levels of PF-3 activity in plasma due to liberation of PF-3 membranes from platelets.


Sign in / Sign up

Export Citation Format

Share Document